Merck’s bezlotoxumab successful in two late-stage studies for prevention of C
Permalink

Merck’s bezlotoxumab successful in two late-stage studies for prevention of C

Bezlotoxumab was developed by researchers at the University of Massachusetts Medical School’s MassBiologics Laboratory in…

Continue Reading →